Exela Technologies Stock Forecast, Price & News

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Exela Technologies in the last year. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" Exela Technologies stock.
View analyst ratings for Exela Technologies or view top-rated stocks.

Wall Street analysts have given Exela Technologies a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Exela Technologies wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Exela Technologies saw a drop in short interest in August. As of August 13th, there was short interest totaling 7,080,000 shares, a drop of 18.9% from the July 29th total of 8,730,000 shares. Based on an average daily trading volume, of 68,620,000 shares, the days-to-cover ratio is currently 0.1 days. Approximately 12.5% of the company's shares are short sold.
View Exela Technologies' Short Interest.

Exela Technologies is scheduled to release its next quarterly earnings announcement on Monday, November 8th 2021.
View our earnings forecast for Exela Technologies.

Exela Technologies, Inc. (NASDAQ:XELA) issued its earnings results on Monday, August, 9th. The company reported ($0.33) earnings per share for the quarter, topping the Zacks' consensus estimate of ($0.45) by $0.12. The company had revenue of $293.01 million for the quarter.
View Exela Technologies' earnings history.

Exela Technologies' stock was trading at $0.6162 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, XELA shares have increased by 240.8% and is now trading at $2.10.
View which stocks have been most impacted by COVID-19.

Exela Technologies's stock reverse split before market open on Tuesday, January 26th 2021. The 1-3 reverse split was announced on Monday, January 25th 2021. The number of shares owned by shareholders was adjusted after the market closes on Monday, January 25th 2021. An investor that had 100 shares of Exela Technologies stock prior to the reverse split would have 33 shares after the split.

Exela Technologies updated its FY 2021 earnings guidance on Tuesday, September, 7th. The company provided EPS guidance of for the period. The company issued revenue guidance of $1.25 billion-$1.39 billion, compared to the consensus revenue estimate of $1.33 billion.

2 equities research analysts have issued 1-year price objectives for Exela Technologies' stock. Their forecasts range from $4.00 to $4.00. On average, they expect Exela Technologies' stock price to reach $4.00 in the next twelve months. This suggests a possible upside of 90.5% from the stock's current price.
View analysts' price targets for Exela Technologies or view top-rated stocks among Wall Street analysts.

140 employees have rated Exela Technologies CEO Ron Cogburn on Glassdoor.com. Ron Cogburn has an approval rating of 46% among Exela Technologies' employees. This puts Ron Cogburn in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Some companies that are related to Exela Technologies include Uxin (UXIN), QuinStreet (QNST), Capita (CTAGY), Viad (VVI), Liquidity Services (LQDT), i3 Verticals (IIIV), Rimini Street (RMNI), MoneyGram International (MGI), Blade Air Mobility (BLDE), Tabula Rasa HealthCare (TRHC), Gravity (GRVY), Newtek Business Services (NEWT), International Money Express (IMXI), Cass Information Systems (CASS) and QIWI (QIWI).
View all of XELA's competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other Exela Technologies investors own include Biocept (BIOC), Acasti Pharma (ACST), Avinger (AVGR), Bionano Genomics (BNGO), Heat Biologics (HTBX), T2 Biosystems (TTOO), Onconova Therapeutics (ONTX), Outlook Therapeutics (OTLK), (SCON) and AgEagle Aerial Systems (UAVS).

Exela Technologies trades on the NASDAQ under the ticker symbol "XELA."

Exela Technologies' stock is owned by many different institutional and retail investors. Top institutional investors include Monashee Investment Management LLC (5.07%), Vanguard Group Inc. (2.81%), Shay Capital LLC (1.34%), Alyeska Investment Group L.P. (1.20%), Goldman Sachs Group Inc. (1.04%) and EJF Capital LLC (0.84%). Company insiders that own Exela Technologies stock include Apollo Management Holdings Gp, and Par Chadha.
View institutional ownership trends for Exela Technologies.

XELA stock was sold by a variety of institutional investors in the last quarter, including Armistice Capital LLC, Alyeska Investment Group L.P., Susquehanna Fundamental Investments LLC, and Vanguard Group Inc..
View insider buying and selling activity for Exela Technologies or view top insider-selling stocks.

XELA stock was purchased by a variety of institutional investors in the last quarter, including Monashee Investment Management LLC, Shay Capital LLC, EJF Capital LLC, Goldman Sachs Group Inc., Morgan Stanley, Morgan Stanley, Susquehanna International Group LLP, and State Street Corp.
View insider buying and selling activity for Exela Technologies or or view top insider-buying stocks.

Shares of XELA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of XELA stock can currently be purchased for approximately $2.10.

Exela Technologies has a market capitalization of $302.49 million and generates $1.29 billion in revenue each year. The company earns $-178,530,000.00 in net income (profit) each year or ($3.66) on an earnings per share basis.

Exela Technologies employs 19,000 workers across the globe.

The official website for Exela Technologies is www.exelatech.com.

Exela Technologies is headquartered at 2701 EAST GRAUWYLER ROAD, IRVING TX, 75061.

Exela Technologies' mailing address is 2701 EAST GRAUWYLER ROAD, IRVING TX, 75061. The company can be reached via phone at 844-935-2832 or via email at [email protected]